Advanced Kidney Disease Treatment in Dubai

CKD is classified into 5 stages based on estimated Glomerular Filtration Rate (eGFR), which measures how well your kidneys filter waste. Stage 1 (eGFR 90+) and Stage 2 (eGFR 60-89) indicate mild damage with relatively preserved function. Stage 3a (eGFR 45-59) and Stage 3b (eGFR 30-44) represent moderate decline requiring closer monitoring. Stage 4 (eGFR 15-29) is severe reduction where preparation for potential renal replacement therapy begins. Stage 5 (eGFR below 15) is kidney failure. Each stage has specific management goals, monitoring intervals, and dietary recommendations. Our aim is to slow progression and keep you at the earliest possible stage.

A kidney-friendly diet is tailored to your CKD stage and lab results. In early stages, reducing sodium intake (less than 2g daily) and maintaining a balanced diet with moderate protein helps protect kidneys. As CKD progresses, restrictions may expand to include potassium (limiting bananas, oranges, potatoes), phosphorus (limiting dairy, processed foods), and protein (to reduce waste buildup). Adequate hydration is important unless fluid restriction is advised in advanced stages. We provide specific dietary guidance based on your blood test results, and can coordinate with a dietitian for detailed meal planning tailored to your cultural food preferences.

Yes, fatigue is one of the most common symptoms of CKD and has multiple causes. As kidneys lose function, waste products (uremic toxins) accumulate in the blood, causing tiredness and difficulty concentrating. Anemia develops because damaged kidneys produce less erythropoietin, the hormone that stimulates red blood cell production. Fluid and electrolyte imbalances, sleep disturbances, and the emotional burden of chronic disease also contribute. Treating anemia with iron supplements and erythropoiesis-stimulating agents, optimizing dialysis if needed, and addressing contributing factors significantly improves energy levels and quality of life.

Most people diagnosed with CKD, especially in early stages, do not progress to needing dialysis. With effective blood pressure control, blood sugar management in diabetes, medication optimization, dietary modifications, and avoidance of nephrotoxic substances, progression can be significantly slowed or stabilized. However, if CKD does progress to Stage 5 kidney failure, dialysis (hemodialysis or peritoneal dialysis) or kidney transplantation becomes necessary to maintain life. We discuss these options well in advance so patients can make informed decisions. Many patients live well on dialysis or thrive after transplantation.

Monitoring frequency depends on your CKD stage and stability. Stage 1-2 patients may need visits every 6-12 months. Stage 3 typically requires every 3-6 months. Stage 4-5 patients need monitoring every 1-3 months as function changes faster and complications require closer attention. Each visit includes blood tests (creatinine, eGFR, electrolytes, hemoglobin), urine tests (albumin), blood pressure review, and medication adjustment. More frequent visits may be needed when starting new medications, managing complications, or if kidney function shows unexpected decline.

Several common medications can harm kidneys or accumulate dangerously with reduced kidney function. Non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and naproxen can worsen kidney function and should be avoided. Certain antibiotics require dose adjustment based on kidney function. Some herbal supplements and over-the-counter medications contain ingredients that are nephrotoxic. Contrast dye used in CT scans can temporarily damage kidneys, requiring special precautions. Your nephrologist reviews all your medications at every visit to ensure renal-safe dosing and to identify any potentially harmful interactions or accumulations.

Diabetic kidney disease (diabetic nephropathy) develops when chronically elevated blood sugar damages the tiny blood vessels and filtering units (glomeruli) in the kidneys. Over time, this damage allows protein to leak into the urine (initially as microalbuminuria, then progressing to overt proteinuria) and gradually reduces the kidneys' filtering capacity. Approximately 30-40% of people with diabetes develop some degree of kidney disease. Tight blood sugar control (HbA1c below 7% for most patients), blood pressure management using ACE inhibitors or ARBs, and newer medications like SGLT2 inhibitors have dramatically improved outcomes for diabetic kidney disease.

Proteinuria is the presence of excess protein (primarily albumin) in the urine, detected through a urine albumin-to-creatinine ratio (UACR) test. Healthy kidneys retain protein in the blood, so protein leaking into urine indicates kidney filter damage. Proteinuria is both a marker of kidney disease severity and a driver of further damage, as protein in the tubules triggers inflammation and scarring. Reducing proteinuria with medications (ACE inhibitors, ARBs, SGLT2 inhibitors) is one of the most important strategies for slowing CKD progression. Regular urine testing tracks your response to treatment.